| # | Drug | Count |
|---|---|---|
| 0 | DIAZEPAM | 145 |
| 1 | DIAZEPAM ORAL | 139 |
| 2 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 139 |
| 3 | PREGABALIN | 98 |
| 4 | METHADONE | 76 |
| 5 | QUETIAPINE | 76 |
| 6 | LORAZEPAM | 49 |
| 7 | CLONAZEPAM | 43 |
| 8 | MORPHINE | 42 |
| 9 | OXAZEPAM | 42 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MICONAZOLE NITRATE, ZINC OXIDE, WHITE PETROLATUM | 1 | 0.0154 |
| 1 | TRIMIPRAMINE | 9 | 0.0082 |
| 2 | COCAINE HYDROCHLORIDE | 2 | 0.0052 |
| 3 | MEPROBAMATE | 4 | 0.0031 |
| 4 | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | 1 | 0.0027 |
| 5 | MILTEFOSINE | 1 | 0.0026 |
| 6 | FLURAZEPAM HYDROCHLORIDE | 1 | 0.0025 |
| 7 | BUPRENORPHINE HCL | 2 | 0.0023 |
| 8 | OXAZEPAM | 42 | 0.0019 |
| 9 | METHADONE | 76 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 220 |
| 1 | Atypical Antipsychotic [EPC] | 103 |
| 2 | Opioid Agonist [EPC] | 65 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 36 |
| 4 | Partial Opioid Agonist [EPC] | 32 |
| 5 | Typical Antipsychotic [EPC] | 28 |
| 6 | beta-Adrenergic Blocker [EPC] | 20 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 14 |
| 8 | Central Nervous System Stimulant [EPC] | 13 |
| 9 | Histamine-1 Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Typical Antipsychotic [EPC] | 28 | 0.0011 |
| 1 | Estrogen Agonist/Antagonist [EPC] | 1 | 0.0004 |
| 2 | Anthelmintic [EPC] | 1 | 0.0003 |
| 3 | Sigma-1 Agonist [EPC] | 3 | 0.0003 |
| 4 | Partial Opioid Agonist [EPC] | 32 | 0.0003 |
| 5 | Vasopressin V2 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 6 | Benzodiazepine [EPC] | 220 | 0.0003 |
| 7 | Opioid Agonist [EPC] | 65 | 0.0002 |
| 8 | Atypical Antipsychotic [EPC] | 103 | 0.0002 |
| 9 | Muscle Relaxant [EPC] | 8 | 0.0002 |